about
Increased CCN2, substance P and tissue fibrosis are associated with sensorimotor declines in a rat model of repetitive overuse injury.Up-regulated expression of substance P in CD8+ T cells and NK1R on monocytes of atopic dermatitis.Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosisMucosal healing and fibrosis after acute or chronic inflammation in wild type FVB-N mice and C57BL6 procollagen α1(I)-promoter-GFP reporter mice.Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.Cathelicidin suppresses colon cancer development by inhibition of cancer associated fibroblastsAnti-fibrogenic effects of the anti-microbial peptide cathelicidin in murine colitis-associated fibrosis.Experimental Models of Inflammatory Bowel Diseases.Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis.SUSTAINED TL1A (TNFSF15) EXPRESSION ON BOTH LYMPHOID AND MYELOID CELLS LEADS TO MILD SPONTANEOUS INTESTINAL INFLAMMATION AND FIBROSIS.Anti-melanin-concentrating hormone treatment attenuates chronic experimental colitis and fibrosis.Inhibition of NMDAR reduces bladder hypertrophy and improves bladder function in cyclophosphamide induced cystitisThe cellular building blocks of breathingHuman monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.Marked Effects of Tachykinin in Myositis Both in the Experimental Side and Contralaterally: Studies on NK-1 Receptor Expressions in an Animal ModelTachykinins and their receptors: contributions to physiological control and the mechanisms of disease.Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells.Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence.Synergism between fibronectin and transforming growth factor-β1 in the production of substance P in monocytes of patients with myelofibrosis.An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis.Neurotensin--regulated miR-133α is involved in proinflammatory signalling in human colonic epithelial cells and in experimental colitis.Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology.Induction of murine TNBS colitis is strictly controlled by a modified method using continuous inhalation anesthesia with sevoflurane.Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.Substance P increases CCN2 dependent on TGF-beta yet Collagen Type I via TGF-beta1 dependent and independent pathways in tenocytes.Upregulated expression of substance P (SP) and NK1R in eczema and SP-induced mast cell accumulation.Proliferation modulates intestinal smooth muscle phenotype in vitro and in colitis in vivo.
P2860
Q28392878-EE1032B2-1439-4B79-ADD1-8BF6DDF371A6Q33623519-41BF9386-E266-414D-B88D-C30CD5D977ECQ33802845-BA538522-B4E3-4F13-80DF-F2DAC634E513Q34374342-B492EA51-9061-4144-ADAD-E6EAF1712A87Q34381832-EB3E82B0-1AA6-445A-969F-897892890FE0Q34757218-C553AA9C-60D7-41E0-BDA6-384F7F3A9DBEQ35113922-A43A13A2-94F5-42E7-881E-A27EDE268D88Q35618798-E14E7BD7-32C9-4C09-A59A-BD4B8FF6CA5DQ35951975-B54C85E2-3AE5-4000-A52B-E88AFA277785Q36800644-B6345C66-1F46-4237-8C51-58C9C00FFE5FQ36837922-B3788DB6-DC54-4737-9A58-334E58CCE624Q36883444-674A1F14-8607-4F71-904E-ECDB4B09DF83Q36933248-400C4095-5C8E-4FB3-9B96-BD7377630E03Q36969841-C890C40A-5DDB-4A4B-BE62-2915BA0D0653Q37153018-EB3B1F27-936D-411B-AF5A-368635C2D8ACQ37593097-283AB3D6-AAC9-4CBE-A288-7342F39C9610Q38033380-E00C7B4A-2ED0-438F-B44E-FE6AAA6483A5Q38865042-965328B4-7B46-420F-9F6E-E0A3BD424407Q39117205-913A0508-A6E4-4780-9640-E1AD9941AA4AQ39294566-8843814C-6FD9-45DD-9FCE-B8909AC63D61Q39901570-8F393EF7-F8C9-49EA-998B-826725EBCB8CQ40373621-CBA0F7BD-B7B5-4A6C-8A06-8F5C79DF6467Q43689427-B2CD0F33-F851-4138-9500-AD83BE5F78EFQ47921122-879739B9-EF8D-4F7B-AC78-724ACBD1FA8EQ47955871-C5968778-4956-4F79-88FE-26F76FD1B79FQ48289453-A04A87FF-5EF3-4C6C-AF10-C046E206BF4BQ52732961-7CB93629-102F-4C57-A41E-B6C5200137F1Q53268986-DF678377-8FA9-4AAF-BEA3-CC2D3CEAD40B
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Substance P modulates colitis-associated fibrosis
@ast
Substance P modulates colitis-associated fibrosis
@en
Substance P modulates colitis-associated fibrosis
@nl
type
label
Substance P modulates colitis-associated fibrosis
@ast
Substance P modulates colitis-associated fibrosis
@en
Substance P modulates colitis-associated fibrosis
@nl
prefLabel
Substance P modulates colitis-associated fibrosis
@ast
Substance P modulates colitis-associated fibrosis
@en
Substance P modulates colitis-associated fibrosis
@nl
P2093
P2860
P1476
Substance P modulates colitis-associated fibrosis
@en
P2093
Charalabos Pothoulakis
David Shih
Dezheng Zhao
Hon Wai Koon
Iordanes Karagiannides
Norma Gerard
Tressia Hing
Zafeer Fazelbhoy
P2860
P304
P356
10.2353/AJPATH.2010.100314
P407
P577
2010-10-01T00:00:00Z